S&P 500 7,673.52 −0.58%
Nasdaq 26,421.41 −0.32%
S&P/TSX 36,123.05 −1.07%
Apple 316.22 −1.17%
Nvidia 225.73 −2.01%
Microsoft 493.95 −1.15%
Shopify 185.03 −7.84%
Royal Bank 288.21 −1.12%
CAD/USD 0.7260 +0.22%
CLOSED · 00:45 ET
Market ClerkRecap
Wed Sep 9 · markets closed1 signal on Sep 8198 insider buys this week · $380.2MCIRO short report next: Sep 14The week ahead
SJ
INSIDER · TXG · 10x Genomics, Inc. · DIRECTOR

STUELPNAGEL JOHN R

Every open-market transaction filed under this name, Sep 3 to Sep 3.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$1.2M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 3TXG10x Genomics, Inc.DirectorSell6,174$62.61$387K−0.3%
Sep 3TXG10x Genomics, Inc.DirectorSell6,814$62.11$423K+0.6%
Sep 3TXG10x Genomics, Inc.DirectorSell7,012$60.66$425K+3.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.